Stock
For a long time, the conversation around artificial intelligence has been dominated by the hardware giants. Companies like Nvidia and Micron have seen their...
Hi, what are you looking for?
Financial commentator Josh Brown has raised an eyebrow at the recent movement of Apple stock, suggesting that the company’s price action is flashing a...
For a long time, the conversation around artificial intelligence has been dominated by the hardware giants. Companies like Nvidia and Micron have seen their...
Connecticut’s pension fund has surged to 76 billion dollars, providing a significant sense of security for state employees and retirees after decades of chronic...
Connecticut’s pension funds saw a significant boost last fiscal year, posting a 15.1 percent increase that added roughly 11 billion dollars to the retirement...
As anticipation builds around a potential public debut for Anthropic, investors are increasingly looking for ways to secure a piece of the action before...
For many dividend investors, the allure of the Schwab U.S. Dividend Equity ETF comes down to a simple and comforting pitch: a steady three...
Jim Cramer is sounding a cautious note for investors as the year winds down, pointing to unsettling similarities between today’s economic climate and the...
What began as a routine administrative review of Portland’s investment policy quickly spiraled into a heated confrontation last week, leaving the City Council divided...
Samsung has decided to lean into a bit of corporate mischief following the debut of Apple’s highly anticipated foldable device, the iPhone Duo. Just...
The energy in Anaheim reached a fever pitch during the BlizzCon 2026 opening ceremony as Blizzard Entertainment unleashed a wave of announcements that felt...
Apple is preparing to shake up the wearable market this September with the debut of the Apple Watch Series 12 and Ultra 4, both...
Investors typically view Federal Reserve rate hikes with a sense of dread, remembering how aggressive tightening cycles can sink portfolios. With current market data...
AstraZeneca shares took a sharp hit during late trading on Friday following disappointing results from a critical clinical trial. Investors reacted quickly as the...